Annual Drug Patent Expirations for MYFEMBREE
Myfembree is a drug marketed by Myovant Sciences and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has eigthy-five patent family members in thirty-two countries.
The generic ingredient in MYFEMBREE is estradiol; norethindrone acetate; relugolix. One supplier is listed for this compound. Additional details are available on the estradiol; norethindrone acetate; relugolix profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
